Expanding Hope for Rare Skin Disease: CHOP Becomes Sixth Treatment Center for Revolutionary ZEVASKYN Gene Therapy

Abeona Therapeutics Inc. has announced a significant expansion in access to ZEVASKYN, marking the activation of Children's Hospital of Philadelphia (CHOP) as the sixth Qualified Treatment Center for this groundbreaking…

Continue Reading Expanding Hope for Rare Skin Disease: CHOP Becomes Sixth Treatment Center for Revolutionary ZEVASKYN Gene Therapy

Bespoke CRISPR Lifeline: First-in-World Gene Editing Treats Infant’s CPS1 Deficiency

When baby KJ was diagnosed with severe carbamoyl phosphate synthetase 1 (CPS1) deficiency—a rare metabolic disorder that can trigger life-threatening ammonia buildup, his family faced a narrow path: strict dietary…

Continue Reading Bespoke CRISPR Lifeline: First-in-World Gene Editing Treats Infant’s CPS1 Deficiency
Writing the Book: How Nicole’s Journey Continues to Raise ALPS Awareness (Pt. 2)
Photo courtesy of Laura Martone-Roublick

Writing the Book: How Nicole’s Journey Continues to Raise ALPS Awareness (Pt. 2)

Before you read, don't forget to check out Part 1 of our interview with Laura, Nicole's mom. In Part 1, we discuss Nicole's diagnostic journey, what acute lymphoproliferative syndrome (ALPS) is,…

Continue Reading Writing the Book: How Nicole’s Journey Continues to Raise ALPS Awareness (Pt. 2)